Jade Biosciences, Inc. Depreciation
Jade Biosciences, Inc. (JBIO) reported Depreciation of $18.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- Jade Biosciences, Inc. depreciation for the quarter ending 2026-06-30 was $9.00K, a 800.00% increase year-over-year.
- Jade Biosciences, Inc. depreciation for the quarter ending 2026-03-31 was $9.00K, a 125.00% increase year-over-year.
- Jade Biosciences, Inc. depreciation for the quarter ending 2025-12-31 was $9.00K, a 12.50% increase year-over-year.
- Jade Biosciences, Inc. depreciation for the quarter ending 2025-09-30 was $12.00K, a 94.50% decline year-over-year.
- Jade Biosciences, Inc. depreciation for fiscal 2025 was $26.00K, a 90.78% decline from fiscal 2024.
- Jade Biosciences, Inc. depreciation for fiscal 2024 was $282.00K, a 193.75% increase from fiscal 2023.
- Jade Biosciences, Inc. depreciation for fiscal 2023 was $96.00K, a 41.18% increase from fiscal 2022.
- Jade Biosciences, Inc. depreciation for fiscal 2022 was $68.00K, a 353.33% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $18.00K 10-Q · filed 2026-08-10 | $27.00K derived: sum of 3 quarters · filed 2026-08-10 | $39.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-07 | $18.00K derived: sum of 2 quarters · filed 2026-05-07 | $30.00K derived: sum of 3 quarters · filed 2026-05-07 | $31.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $21.00K derived: sum of 2 quarters · filed 2026-03-06 | $22.00K derived: sum of 3 quarters · filed 2026-08-10 | $26.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $13.00K derived: sum of 2 quarters · filed 2026-08-10 | $17.00K 10-Q · filed 2025-11-14 | $25.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.00K 10-Q · filed 2026-08-10 | $13.00K derived: sum of 3 quarters · filed 2026-08-10 | $231.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $4.00K 10-Q · filed 2025-04-25 | $12.00K derived: sum of 2 quarters · filed 2025-04-25 | $230.00K derived: sum of 3 quarters · filed 2025-04-25 | $258.00K derived: sum of 4 quarters · filed 2025-04-25 |
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $226.00K derived: sum of 2 quarters · filed 2025-03-27 | $254.00K derived: sum of 3 quarters · filed 2025-03-27 | $282.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $246.00K derived: sum of 2 quarters · filed 2024-11-12 | $274.00K 10-Q · filed 2024-11-12 | $302.00K derived: sum of 4 quarters · filed 2025-04-25 |
| 2024-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $56.00K 10-Q · filed 2024-08-12 | $84.00K derived: sum of 3 quarters · filed 2025-04-25 | $109.00K derived: sum of 4 quarters · filed 2025-04-25 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-04-25 | $56.00K derived: sum of 2 quarters · filed 2025-04-25 | $81.00K derived: sum of 3 quarters · filed 2025-04-25 | $103.00K derived: sum of 4 quarters · filed 2025-04-25 |
| 2023-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $53.00K derived: sum of 2 quarters · filed 2025-03-27 | $75.00K derived: sum of 3 quarters · filed 2025-03-27 | $96.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $47.00K derived: sum of 2 quarters · filed 2024-11-12 | $68.00K 10-Q · filed 2024-11-12 | $88.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $43.00K 10-Q · filed 2024-08-12 | $63.00K derived: sum of 3 quarters · filed 2024-08-12 | $83.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $21.00K 10-Q · filed 2024-05-13 | $41.00K derived: sum of 2 quarters · filed 2024-05-13 | $61.00K derived: sum of 3 quarters · filed 2024-05-13 | $78.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $40.00K derived: sum of 2 quarters · filed 2024-03-25 | $57.00K derived: sum of 3 quarters · filed 2024-03-25 | $68.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $37.00K derived: sum of 2 quarters · filed 2023-11-13 | $48.00K 10-Q · filed 2023-11-13 | $56.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $28.00K 10-Q · filed 2023-08-14 | $36.00K derived: sum of 3 quarters · filed 2023-08-14 | $39.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-15 | $19.00K derived: sum of 2 quarters · filed 2023-05-15 | $22.00K derived: sum of 3 quarters · filed 2023-05-15 | $24.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $11.00K derived: sum of 2 quarters · filed 2023-03-29 | $13.00K derived: sum of 3 quarters · filed 2023-03-29 | $15.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $5.00K derived: sum of 2 quarters · filed 2022-11-14 | $7.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $4.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $1.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |